Stem cells repair damaged retinas in mice; Atlanta gets new cancer research center;

Stem cell research

University of Florida researchers were able to program bone marrow stem cells to repair damaged retinas in mice, suggesting a potential treatment for one of the most common causes of vision loss in older people. Release

Genetics

Scientists have identified a genetic defect that could be responsible for up to half of all cases of epilepsy. Article

Researchers say a "gene signature" found in resistant cancer cells that remain after a woman with breast cancer undergoes treatment may lead to new drug targets. Release

Cancer research

Using a novel delivery system, researchers at the University of Texas M. D. Anderson Cancer Center were able to successfully targeted a protein that is over-expressed in ovarian cancer cells. The protein is also found in other types of cancer, including breast, colon, and prostate and non-small cell lung cancers, but is "virtually absent" in normal cells, the study's senior author said. Release

Clark Atlanta University's Center for Cancer Research and Therapeutic Development and Georgia Tech's Integrative Cancer Research Center have teamed up to launch the Collaborative Cancer Genomics Center, a state-of-the-art $5 million gene sequencing facility at Clark Atlanta. The collaboration will focus on exploring the genetics behind prostate, ovarian, pancreatic and lung cancers. Report

And Finally... Pneumonic plague has killed three people in China, though health officials say there's little chance that the outbreak will cause mass fatalities. Report

Suggested Articles

Compass' CD137 agonist cleared large tumors in mice that other I-O agents had failed to treat. It's advancing the drug into phase 1 human trials.

UPMC researchers are planning clinical trials of a COVID-19 vaccine that uses pieces of the virus' spike protein to create immunity.

Treating mice with niacin increased the number of immune cells in glioblastomas, reducing tumor size and extending survival.